WHO ICTRP trial

A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory…

JPRN-jRCT2080221995 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-jRCT2080221995
Public title A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory Study of DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation
Scientific title A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory Study of DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation (Early Phase 2 Study)
Primary sponsor Sumitomo Dainippon Pharma Co.,Ltd.
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase 2
Countries Japan
Conditions Irritable bowel syndrome with constipation
Interventions investigational material(s) Generic name etc : DSP-6952 INN of investigational material : minesapride Therapeutic category code : 2-- Agents affecting individual organs Dosage and Administration for Investigational material : Oral…
Registration date Dec 28, 2012
Target size 165
Secondary IDs JapicCTI-122041
Registry page jrct.niph.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations